All products on this site are for in-vitro research, research use only. Products are not for human consumption of any kind.

Therapeutic Advances in Urology

“Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in mice with locally advanced or metastatic prostate cancer”​1​

  1. 1.
    Lebret T, Rouanne M, Hublarov O, et al. Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in mice with locally advanced or metastatic prostate cancer. Therapeutic Advances in Urology. Published online March 17, 2015:125-134. doi:10.1177/1756287215577329